MicroRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis

Oncogene

Volumn 32, Issue 42, 2013, Pages 5078-5088

  Zhang, N ^a,b   Li, X ^a   Wu, C W ^a   Dong, Y ^a   Cai, M ^c   Mok, M T S ^a   Wang, H ^a   Chen, J ^b   Ng, S S M ^a   Chen, M ^b   Sung, J J Y ^a   Yu, J ^a,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Colorectal cancer; MiR 7; P53; Wnt; YY1

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 7; CASPASE 9; FIBROBLAST GROWTH FACTOR 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 7; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN C JUN; PROTEIN P15; PROTEIN P53; SURVIVIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG; WNT1 PROTEIN; WNT3A PROTEIN; WNT4 PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CARCINOGENESIS; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; UPREGULATION; WNT SIGNALING PATHWAY;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, P53; HCT116 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE, NUDE; MICRORNAS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS; YY1 TRANSCRIPTION FACTOR;

MUS MUSCULUS;

EID: 84886101574     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.526     Document Type: Article

References (40)

1. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B et al. Colorectal cancer. Lancet 2010; 375: 1030-1047.
2. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut 2011; 60: 116-129.
3. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009; 9: 489-499.
4. Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K et al. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011; 32: 247-253.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Nugent M, Miller N, Kerin MJ. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 2011; 37: 649-654.
7. Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012; 61: 739-745.
8. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381.
9. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006; 29: 903-906.
10. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385-1392.
11. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472-15477. (Pubitemid 47502941)
12. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010; 70: 6609-6618.
13. Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko Jr. RJ et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009; 69: 8157-8165.
14. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-2460.
15. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68: 3566-3572.
16. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 2010; 432: 199-205.
17. Reddy SD, Ohshiro K, Rayala SK, Kumar R. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 2008; 68: 8195-8200.
18. Begon DY, Delacroix L, Vernimmen D, Jackers P, Winkler R. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J Biol Chem 2005; 280: 24428-24434. (Pubitemid 40934527)
19. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 2005; 27: 131-141.
20. Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B et al. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 2007; 31: 69-79.
21. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 1994; 13: 1460-1466. (Pubitemid 24090228)
22. Dong XP, Stubenrauch F, Beyer-Finkler E, Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994; 58: 803-808. (Pubitemid 24306367)
23. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342-348. (Pubitemid 32467043)
24. Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998; 2: 283-292. (Pubitemid 128379269)
25. Wieler S, Gagne JP, Vaziri H, Poirier GG, Benchimol S. Poly(ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation. J Biol Chem 2003; 278: 18914-18921. (Pubitemid 36799274)
26. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999; 13: 607-619. (Pubitemid 29131884)
27. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6: 443-450. (Pubitemid 38607505)
28. Kimura Y, Furuhata T, Urano T, Hirata K, Nakamura Y, Tokino T. Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. Genomics 1997; 41: 477-480. (Pubitemid 27194804)
29. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 2000; 275: 7337-7342. (Pubitemid 30146286)
30. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P et al. Yin Yang 1 is a negative regulator of p53. Cell 2004; 117: 859-872. (Pubitemid 38798853)
31. Gronroos E, Terentiev AA, Punga T, Ericsson J. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 2004; 101: 12165-12170. (Pubitemid 39145414)
32. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS et al. Smallmolecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nat Chem Biol 2010; 6: 829-836.
33. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y et al. Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 2000; 14: 1741-1749. (Pubitemid 30602993)
34. Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004; 18: 1222-1237. (Pubitemid 38591287)
35. Dale TC. Signal transduction by the Wnt family of ligands. Biochem J 1998; 329: (Part 2): 209-223. (Pubitemid 28040782)
36. Yokoyama NN, Pate KT, Sprowl S, Waterman ML. A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res 2010; 38: 6375-6388.
37. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921. (Pubitemid 27353455)
38. Buckland RA, Collinson JM, Graham E, Davidson DR, Hill RE. Antagonistic effects of FGF4 on BMP induction of apoptosis and chondrogenesis in the chick limb bud. Mech Dev 1998; 71: 143-150. (Pubitemid 28153526)
39. Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD et al. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol 2002; 3: 1102-1108. (Pubitemid 35363665)
40. Su DM, Navarre S, Oh WJ, Condie BG, Manley NR. A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation. Nat Immunol 2003; 4: 1128-1135. (Pubitemid 37428041)